Case Report
Published on 25 Sep 2025
Case Report: Bowen’s disease treated with PD-1 inhibitor and chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1654431
- 196 views
Type at least 3 characters
1,494 articles
Original Research
Accepted on 24 Sep 2025
Blood-derived Ratio Indexes Associated with Severity and Prognosis of Immune Checkpoint Inhibitor-related Cardiotoxicity:A Retrospective Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1676806
Case Report
Accepted on 23 Sep 2025
Diagnosis and Treatment of Giant thoracodorsal Liposarcoma: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1570796
- 226 views
Original Research
Accepted on 23 Sep 2025
The Role of Immune-and Lipid Metabolism-Related Genes in Macrophage Polarization and Prognosis of Glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1660754
- 160 views
Original Research
Accepted on 23 Sep 2025
Ferroptosis's Master Switch GPX4 Emerges as Universal Biomarker for Precision Immunotherapy: A Pan-cancer Study with in vitro experiments validation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1643235
- 231 views
Original Research
Accepted on 22 Sep 2025
Treatment experience in managing severe immune-mediated hepatotoxicity induced by immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1657332
- 1,116 views
Original Research
Accepted on 22 Sep 2025
Dextran sulfate inhibits the invasion, migration, and programmed death ligand 1 expression in human gastric cancer cells by affecting the M2 tumor-associated macrophages polarization
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1689053
- 140 views
Systematic Review
Accepted on 22 Sep 2025
The effect of Tislelizumab on Complete and Pathological Complete Response in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1657282
- 195 views
Original Research
Accepted on 22 Sep 2025
Predictive Value of Early Changes in Serum CEA, CYFRA21-1, and SCC-Ag for Efficacy and Prognosis in Advanced Lung Squamous Cell Carcinoma Treated with First-Line Immunotherapy Combined with Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1561602
- 132 views
Review
Published on 22 Sep 2025
Advances in the mechanism and therapeutic potential of neutrophil extracellular traps in cancer promotion
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1593510
- 530 views
Original Research
Published on 22 Sep 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge therapy in the treatment of advanced acquired immune-resistant non-small cell lung cancer: a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621860
- 495 views
Original Research
Accepted on 19 Sep 2025
Personalized medicine in Triple-Negative Breast Cancer: Combining Neoantigen Vaccination and Genomic Profiling in a patient Undergoing Neoadjuvant Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1623402
- 555 views
Case Report
Published on 18 Sep 2025
Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1664171
- 677 views
Brief Research Report
Accepted on 17 Sep 2025
Evaluating the Impact of Immune Checkpoint Inhibitors on Liver Steatosis and Function: A Retrospective Cohort Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1683982
- 547 views
Case Report
Accepted on 16 Sep 2025
Failed response to anti-PD-1 immunotherapy in a colon cancer patient with high microsatellite instability: A case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1636122
- 721 views
Mini Review
Accepted on 16 Sep 2025
Microbiome-Mediated Regulation of Chemoradiotherapy Response
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1659467
- 435 views